Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones

TY - JOUR

T1 - Thiopurine Therapy in Inflammatory Bowel Diseases

T2 - Making New Friends Should Not Mean Losing Old Ones

AU - Thiopurine Working Group

AU - de Boer, Nanne K.H.

AU - Ahuja, Vineet

AU - Almer, Sven

AU - Ansari, Azhar

AU - Banerjee, Rupa

AU - Barclay, Murray L.

AU - Begun, Jake

AU - van Bodegraven, Adriaan A.

AU - Colombel, Jean Frederic

AU - Epstein, David P.

AU - Florin, Timothy H.J.

AU - Gearry, Richard B.

AU - Gisbert, Javier P.

AU - Leong, Rupert W.

AU - Mulder, Chris J.J.

AU - Neurath, Markus F.

AU - Radford-Smith, Graham L.

AU - Seinen, Margien L.

AU - Simsek, Melek

AU - Sparrow, Miles P.

N1 - Funding Information: The Thiopurine Working Group is represented by (in alphabetic order): Vineet Ahuja, India Institute of Medical Sciences, Department of Gastroenterology and Human Nutritions, New Delhi, India; Sven Almer, Karolinska Institutet, Department of Medicine, Solna, Stockholm, Sweden (1) and Karolinska University Hospital, Department of Gastroenterology, Dermatology and Rheumatology, Stockholm, Sweden (2); Azhar Ansari, East Surrey Hospital, Department for Digestive Diseases, Surrey and Sussex Healthcare NHS Trust, Redhill, United Kingdom; Rupa Banerjee, Asian Institute of Gastroenterology, Department of Medical Gastroenterology, Hyderabad, India; Murray L. Barclay, Christchurch Hospital, Department of Gastroenterology, Christchurch, New Zealand; Jake Begun, Mater Hospital Brisbane, and Mater Research Institute, University of Queensland, Brisbane, Australia; Adriaan A. van Bodegraven, Zuyderland Medical Centre, Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co-MIK), Heerlen-Sittard-Geleen, The Netherlands (1) and Amsterdam UMC, Vrije Universiteit, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands (2); Jean-Frederic Colombel, Icahn School of Medicine at Mount Sinai, New York, New York; David P. Epstein, IBD Africa, Vincent Pallotti Hospital, Division of Medicine, Cape Town, South Africa; Timothy H.J. Florin, University of Queensland, Translational Research Institute, Mater Research, Queensland, Australia; Richard B. Gearry, Christchurch Hospital, University of Otago, Department of Medicine, Christchurch, New Zealand; Javier P. Gisbert, Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain; Rupert W. Leong, Concord Repatriation General Hospital, Gastroenterology and Liver Services, Concord NSW, Australia; Chris J.J. Mulder, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam, the Netherlands; Markus F. Neurath, Universitätsklinikum Erlangen and University of Erlangen-Nürnberg, Department of Gastroenterology, Pneumology and Endocrinology, Erlangen, Germany; Graham L. Radford-Smith, Royal Brisbane and Women’s Hospital, QIMR Berghofer Medical Research Institute, and University of Queensland School of Medicine, Brisbane, Australia; Margien L. Seinen, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam, the Netherlands; Melek Simsek, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam, the Netherlands; and Miles P. Sparrow, The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia.

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85058876383&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2018.11.039

DO - 10.1053/j.gastro.2018.11.039

M3 - Editorial

C2 - 30472233

AN - SCOPUS:85058876383

SN - 0016-5085

VL - 156

SP - 11

EP - 14

JO - Gastroenterology

JF - Gastroenterology

IS - 1

ER -